Recurrence risk and prediction of a delivery under 34 weeks of gestation after a history of a severe hypertensive disorder

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 5, 2011, Pages 589-595

  Langenveld, J ^a   Buttinger, A ^b   Van Der Post, J ^b   Wolf, H ^b   Mol, B W ^b   Ganzevoort, W ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Pre eclampsia; Preterm recurrence; Severe

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PARAMETER; PREDICTION; PREDICTOR VARIABLE; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BIRTH WEIGHT; BODY MASS INDEX; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; RECURRENCE; RISK FACTORS;

EID: 79952661789     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02842.x     Document Type: Article

References (21)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365: 785-99.
2. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-92. (Pubitemid 36792143)
3. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.
4. Witlin AG, Saade GR, Mattar F, Sibai BM. Predictors of neonatal outcome in woman with severe preeclampsia between 24 and 33 weeks'gestation. Am J Obstet Gynecol 2000;182:607-11. (Pubitemid 30207320)
5. Ganzevoort W, Rep A, de Vries JI, Bonsel GJ, Wolf H; PETRA-investigators. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol 2006;195:495-503. (Pubitemid 44142383)
6. Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads CA, et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal Acta Obstet Gynecol Scand 2009;88:758-65.
7. Hernández-Diaz S, Toh S, Cnattinguis S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 2009;338:b2255.
8. Van Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 2001;20:15-23. (Pubitemid 32672924)
9. Van Pampus MG, Wolf H, Weijmar Shultz WC, Neeleman J, Aarnoudse JG. Posttraumatic stress disorder following preeclampsia and HELLP syndorme. J Psychosom Obstet Gynaecol 2004;25:183-7. (Pubitemid 40127665)
10. Rep A, Ganzevoort W, Bonsel GJ, Wolf H, de Vries JI. Psychosocial impact of early-onset hypertensive disorders and related complications in pregnancy. Am J Obstet Gynecol 2007;197:158e1-6.
11. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:125-9.
12. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
13. The Netherlands Perinatal Registry [homepage on the internet]. Utrecht: PRN-foundation [Available from: www.perinatreg.nl/home-english]. Last accessed 1 November 2009.
14. Langenveld J, Jansen S, van der Post JA, Wolf H, Mol BW, Ganzevoort W. Recurrence risk of a delivery before 34 weeks of pregnancy due to a severe hypertensive disorder: a systematic review. Am J Perinatol 2010;27:565-71.
15. Van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006;195:723-8. (Pubitemid 44292141)
16. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408-12.
17. (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
18. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH; Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:1145-54.
19. Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, et al.; INTAPP study group. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 2010; 202:239.e1-10.
20. Spinnato JA II, Freire S, Pinto E Silva JL, Cunha Rudge MV, Martins-Costa S, Koch MA, et al. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol 2007;110:1311-8. (Pubitemid 351326075)
21. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338: 701-5.